全文获取类型
收费全文 | 154003篇 |
免费 | 32468篇 |
国内免费 | 2401篇 |
专业分类
耳鼻咽喉 | 5226篇 |
儿科学 | 5578篇 |
妇产科学 | 2568篇 |
基础医学 | 4125篇 |
口腔科学 | 1498篇 |
临床医学 | 27042篇 |
内科学 | 47888篇 |
皮肤病学 | 7589篇 |
神经病学 | 15113篇 |
特种医学 | 6466篇 |
外科学 | 41491篇 |
综合类 | 264篇 |
现状与发展 | 72篇 |
预防医学 | 7207篇 |
眼科学 | 3489篇 |
药学 | 1171篇 |
中国医学 | 11篇 |
肿瘤学 | 12074篇 |
出版年
2024年 | 686篇 |
2023年 | 4792篇 |
2022年 | 1211篇 |
2021年 | 3093篇 |
2020年 | 6041篇 |
2019年 | 2183篇 |
2018年 | 7426篇 |
2017年 | 7358篇 |
2016年 | 8443篇 |
2015年 | 8461篇 |
2014年 | 15529篇 |
2013年 | 15693篇 |
2012年 | 5602篇 |
2011年 | 5584篇 |
2010年 | 10411篇 |
2009年 | 14313篇 |
2008年 | 5901篇 |
2007年 | 4153篇 |
2006年 | 6606篇 |
2005年 | 3905篇 |
2004年 | 3161篇 |
2003年 | 2144篇 |
2002年 | 2226篇 |
2001年 | 4014篇 |
2000年 | 3207篇 |
1999年 | 3369篇 |
1998年 | 3711篇 |
1997年 | 3516篇 |
1996年 | 3419篇 |
1995年 | 3250篇 |
1994年 | 1979篇 |
1993年 | 1609篇 |
1992年 | 1463篇 |
1991年 | 1514篇 |
1990年 | 1145篇 |
1989年 | 1298篇 |
1988年 | 1114篇 |
1987年 | 933篇 |
1986年 | 967篇 |
1985年 | 798篇 |
1984年 | 599篇 |
1983年 | 565篇 |
1982年 | 535篇 |
1981年 | 424篇 |
1980年 | 386篇 |
1979年 | 346篇 |
1978年 | 360篇 |
1977年 | 424篇 |
1975年 | 321篇 |
1972年 | 338篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves
a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because
of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address
issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment
should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these
are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating
a successful pharmacologic treatment program for patients with fibromyalgia. 相似文献
92.
93.
94.
Christiana Winkler Barbara Frick Katharina Schroecksnadel Harald Schennach Dietmar Fuchs 《Food and chemical toxicology》2006,44(12):2003-2007
Antioxidant preservatives prolong the quality of food and ensure the nutritional adequacy, palatability and safety of many processed foods and beverages. Effects of sodium sulfite (E221) and sorbic acid (E200) were investigated in human peripheral blood mononuclear cells (PBMC) which were purified from blood of healthy donors. Cells were stimulated with the mitogen phytohaemagglutinin in vitro, which induces proliferation of T-cells and the production of Th1-type cytokines like interferon-γ. The latter triggers enzyme indoleamine (2,3)-dioxygenase, which degrades tryptophan, and GTP cyclohydrolase I, which leads to increased neopterin production, in monocyte-derived macrophages. Sodium sulfite and sorbic acid suppressed both these biochemical changes in a dose-dependent way (P < 0.01 at 1 mM sodium sulfite and 50 mM sorbic acid). Data demonstrate a suppressive influence of sodium sulfite and sorbic acid on the activated Th1-type immune response. 相似文献
95.
96.
97.
98.
Toshio Imaizumi MD PhD Toshimi Honma MD PhD Yoshifumi Horita MD Ikuhide Kohama MD PhD Kei Miyata MD Maiko Kawamura MD Jun Niwa MD PhD 《Journal of neuroimaging》2006,16(3):236-242
BACKGROUND AND PURPOSE: Dot-like low intensity spots (dot-like hemosiderin spots: dotHSs) on gradient echo T2*-weighted MRI have been histologically diagnosed to represent old cerebral microbleeds associated with microangiopathies. They have also been correlated to the fragility of small vessels and the tendency to bleed. Therefore, a substantial number of dotHSs might be associated with a large-sized, deep intracerebral hematoma (ICH). On the other hand, dotHSs may reflect old microbleeds that did not enlarge to symptomatic size. METHODS: To investigate how dotHSs are related to the size (maximal diameter) of primary deep ICH, we analyzed the diameter and the number of dotHSs in 151 patients with deep ICH not associated with subarachnoid hemorrhage or intraventricular hemorrhage (75 males and 76 females, age ranged from 37 to 90 [65.7 +/- 11.3 years old] who were consecutively admitted to Hakodate Municipal Hospital. The hazard ratio (HR) for a maximal diameter of deep ICH < or =2 cm was estimated, using the number of dotHSs and risk factors for stroke. RESULTS: The number of dotHSs associated with the diameter < or =2 cm was 9.2 +/- 11.5, significantly larger than that with the diameter > or =2 cm (4.7 +/- 7.0, P= .012). Multivariate analysis revealed that a maximal diameter of deep ICH of < or =2 cm was found in patients with dotHS (HR, 3.7; 95% confidence interval [CI], 1.4-10.1; P= .009). CONCLUSION: Though small sample size limited the power of our analyses, these findings suggest that the number of dotHSs may be associated with a small diameter of deep ICH. 相似文献
99.
100.
Lucia Nogovà MD Volker Diehl MD Andreas Engert MD 《Current hematologic malignancy reports》2006,1(1):60-65
Lymphocyte-predominant Hodgkin’s lymphoma (LPHL) differs in histologic and clinical presentation from classical Hodgkin’s
lymphoma (cHL). Treatment of LPHL patients using standard Hodgkin’s lymphoma protocols leads to complete remission in more
than 95% of patients. Survival and freedom from treatment failure are substantially worse in advanced-stage patients than
for early-stage patients. Thus, patients in advanced stages and those in early stages with unfavorable risk factors should
be treated similar to those with cHL. In contrast, patients with early-stage LPHL without risk factors might be sufficiently
treated with reduced-intensity programs having less severe adverse effects. As a result, treatment of early LPHL is rather
heterogeneous, including radiotherapy using extended-fleld technique, involved-fleld radiotherapy (IF-RT), combined-modality
treatment, and, more recently, monoclonal antibodies. Watch-and-wait strategy plays an important role in pediatric oncology,
to avoid adverse effects associated with therapy. IF-RT seems to be emerging as a treatment of choice for patients with stage
IA LPHL; most larger study groups, such as the German Hodgkin Study Group and the European Organisation for Research and Treatment
of Cancer, have adopted IF-RT as the treatment of choice for these patients. 相似文献